Actively Recruiting

Phase Not Applicable
Age: 14Years +
All Genders
NCT03932903

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Led by Northwestern University · Updated on 2025-12-23

60

Participants Needed

1

Research Sites

56 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

This is a small-scale micro-randomized clinical trial of a new mobile just-in-time adaptive intervention (JITAI) designed to promote oral chemotherapy adherence in adolescents and young adults (AYA) with acute lymphoblastic leukemia (ALL). The goals of this study are to determine intervention feasibility and acceptability.

CONDITIONS

Official Title

Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia

Who Can Participate

Age: 14Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Ages 14 to 29 years
  • Diagnosed with acute lymphoblastic leukemia (ALL) or lymphoma
  • In the maintenance phase of treatment with at least one month of maintenance therapy remaining
  • Prescribed 6-mercaptopurine (6-MP)
  • Able to understand and use English
  • For participants under 18, informed consent from caregiver is required
  • Caregivers must be nominated by the participant as a primary caregiver involved in cancer care
  • Caregivers must be able to read and understand English
Not Eligible

You will not qualify if you...

  • Cognitive impairments that limit ability to complete study measures, as determined by the medical team
  • Not meeting the inclusion criteria listed above
  • Caregivers who do not meet the inclusion criteria

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Robert H. Lurie Comprehensive Cancer Center, Northwestern University

Chicago, Illinois, United States, 60611

Actively Recruiting

Loading map...

Research Team

A

Alexandra M Psihogios, Ph.D.

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

SUPPORTIVE_CARE

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here